Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002406047 | SCV002710675 | uncertain significance | Cardiovascular phenotype | 2019-07-18 | criteria provided, single submitter | clinical testing | The p.R5608Q variant (also known as c.16823G>A), located in coding exon 65 of the TTN gene, results from a G to A substitution at nucleotide position 16823. The arginine at codon 5608 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003138250 | SCV003819061 | uncertain significance | not provided | 2019-07-10 | criteria provided, single submitter | clinical testing |